ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

3.49
0.08
(2.35%)
Closed 22 December 8:00AM
3.50
0.01
(0.29%)
After Hours: 10:38AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 33.14M33.2M38.01M48.32M44.39M40.64M48.07M54.27M
Operating Income -15.17M-13.28M-15.98M-4.91M-9.84M-14.25M-8.19M-12.89M
Pre Tax Income -13.27M-16.83M-20.52M-12.53M-13.63M-18.67M-14.26M-19.06M
Net Income -12.93M-16.83M-19.84M-12.19M-13.39M-18.98M-15.01M-15.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -10.76M-11.92M-15.2M-3.98M-7.71M-13.57M-7.59M-12.47M
EBITDA -12.09M-10.2M-12.88M-1.81M-6.78M-11.21M-5.2M-9.88M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 49.59M110.25M163.91M
Operating Income -115.16M-81.94M-44.01M
Pre Tax Income -122.73M-96.08M-63.5M
Net Income -122.73M-94.66M-62.26M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.983-0.695-0.451
EBIT -115.16M-85.1M-38.81M
EBITDA -113.28M-69.7M-31.68M

Your Recent History

Delayed Upgrade Clock